Intellectual Property News - Secerna LLP

Cell Therapy

In-depth Series: EPO Case Law relating to cell therapies: a summary of 2025

European Industry News News 29/01/2026

Here, we take a closer look at a selection of decisions from 2025 that highlight the recent patentability and procedural issues seen in the field of cell-based therapeutics.

Read more

CERDELGA

News, A to Z Feature 04/12/2024

A to Z: Drugs in Highlight: C is for CERDELGA

Secerna Website Images 2023 (63)

European, Industry news, News 03/12/2024

Extension of the European Patent Office’s Patent Prosecution Highway Programme

A To Z Drugs In Highlight B Is For BREO ELLIPTA

Industry news, News, A to Z Feature 28/11/2024

A to Z: Drugs in Highlight: B is for BREO ELLIPTA

Secerna Shares IP Law Insights With Durham University Students

Industry news, News, Careers 26/11/2024

Secerna Sparks Interest in IP Law at Durham University

EPO 2021

European, Industry news, News 19/11/2024

Unitary Patent: Legal provision to implement EU sanctions against Russia

A to Z: Drugs in Highlight: A is for AKEEGA®

News, A to Z Feature 15/11/2024

A to Z: Drugs in Highlight: A is for AKEEGA®

European, Industry news, News 13/11/2024

Sweden Aims to Protect Its Brand with Trademark Application

Celebrating Chemistry Week 2024: Funding Schemes and Support Options

Industry news, News 07/11/2024

Celebrating Chemistry Week 2024: Funding Schemes and Support Options

JROBERTS - Secerna

Events, News 05/11/2024

Secerna to discuss IP at Manufacturing & Engineering North East (MENE)

11 12 13 14 15 16 17 18 19 20 21